A Decision Analysis Evaluating Screening for Kidney Cancer Using Focused Renal Ultrasound
Open Access
- 1 March 2021
- journal article
- research article
- Published by Elsevier BV in European Urology Focus
- Vol. 7 (2), 407-419
- https://doi.org/10.1016/j.euf.2019.09.002
Abstract
No abstract availableThis publication has 78 references indexed in Scilit:
- Pazopanib versus Sunitinib in Metastatic Renal-Cell CarcinomaThe New England Journal of Medicine, 2013
- A Review of Contemporary Data on Surgically Resected Renal Masses—Benign or Malignant?Urology, 2013
- Cost-utility analysis of radical nephrectomy versus partial nephrectomy in the management of small renal masses: adjusting for the burden of ensuing chronic kidney diseaseCanadian Urological Association Journal, 2013
- Pazopanib for the First-Line Treatment of Patients with Advanced and/or Metastatic Renal Cell CarcinomaPharmacoEconomics, 2012
- Solitary solid renal mass: can we predict malignancy?BJU International, 2012
- Tumor Size is Associated With Malignant Potential in Renal Cell Carcinoma CasesJournal of Urology, 2009
- Economic evaluation of sunitinib malate in second-line treatment of metastatic renal cell carcinoma in FinlandClinical Therapeutics, 2008
- Teledentistry for screening new patient orthodontic referrals. Part 1: A randomised controlled trial.British Dental Journal, 2005
- Screening computed tomographyCancer, 2004
- Validity of sonographic screening for the detection of abdominal cancersJournal of Clinical Ultrasound, 2002